What is it about?
Endometriosis is a chronic, neuro-inflammatory disease that occurs when endometrial tissue, normally confined to the uterus, spreads to other areas within the pelvic cavity and beyond. This review summarises the recent NICE guidelines, including the new recommendations and updates of existing ones on diagnosing and managing this condition that affects approximately 1.5 million women of reproductive age in the UK.
Featured Image
Photo by Lekan Ridwan on Unsplash
Why is it important?
Endometriosis is estimated to affect up to 10% of reproductive-aged women, causing debilitating pain, affecting daily activities and can have a significant adverse effect on quality of life. The updated guideline aims to help address these issues by making firmer and clearer recommendations regarding referral thus expediting treatment and widening options. There are updates on specialist ultrasound for all people with suspected endometriosis, and expanded pharmacological management options. The aim is to provide greater clarity about the care available for women with suspected endometriosis.
Perspectives
Endometriosis is a condition which has historically been side-lined as something which is tolerated by women as part of menstrual health. There has been limited research undertaken and only in recent years has this been rectified.
Dr Sonya MacVicar
Edinburgh Napier University
Read the Original
This page is a summary of: Primary care assessment of endometriosis, Practice Nursing, May 2026, Mark Allen Group,
DOI: 10.12968/pnur.2026.0004.
You can read the full text:
Contributors
The following have contributed to this page
